Innovations for better health
Our research focuses mainly on therapeutic areas with significant unmet medical need. Every year, we invest between 15 and 17 percent of our total net sales in research and development.
In drug discovery we concentrate on new treatments in the fields of cancer, cardiovascular diseases and gynecological therapies, as well as new approaches to molecular imaging. To develop new drug candidates, we focus on identifying and optimizing small molecules and developing new biologics. more
In drug discovery we concentrate on new treatments in the fields of cancer, cardiovascular diseases and gynecological therapies, as well as new approaches to molecular imaging. To develop new drug candidates, we focus on identifying and optimizing small molecules and developing new biologics. more